Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the efficacy of bicyclol in preventing chemotherapy-induced liver damage.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Int. Med. Res.

Title: The Journal of international medical research

Publisher: SAGE Publications

ISSN (Electronic): 1473-2300

ISSN (Print): 0300-0605

Publication date (Electronic): Aug 2014

Volume: 42

Issue: 4

Affiliations

[1 ] Department of Medical Oncology, Peking Union Medical College Hospital, Beijing, China.

[2 ] Department of Medical Oncology, Peking Union Medical College Hospital, Beijing, China phoenixzhou@hotmail.com.

Article

Publisher Item ID: 0300060514527058

DOI: 10.1177/0300060514527058

PubMed ID: 24903556

SO-VID: 441d0a46-3a1c-4107-a686-caf82404056b

History

Keywords: Bicyclol,cancer,chemotherapy-induced liver injury,elderly people,hepatic injury,prophylaxis

Data availability:

Keywords: Bicyclol, cancer, chemotherapy-induced liver injury, elderly people, hepatic injury, prophylaxis

Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer.

Read this article at

Abstract

Related collections

International Journal of Medicine and Medical Research

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 9